Immunological variables and tumor types influence one-year survival probability in cancer patients: A comprehensive analysis using logistic regression and decision tree models
Lopez Malizia, A.
Show abstract
The present study aimed to explore immunological variables associated with survival, TP53 gene expression, and primary diagnosis in patients with cancer. Based on these variables, logistic regression and decision tree models (lightGBM) were used to model the probability of one-year survival of patients following their initial diagnosis. Logistic regression revealed the significance of primary diagnosis categories such as Malignant Melanoma, Ovarian Cancer, and Glioblastoma as predictor variables. For the classification model, in addition to these tumor types, variables related to the immune system were also found to be important, including tumor cell percentage, stromal cell percentage, lymphocytes, and necrotic cells. In addition, unsupervised classification techniques were employed to explore the numerical dataset. For this methodology, the best clustering cohesion was observed with two groups determined using different algorithms. The clusters generated by k-means and DBSCAN exhibited differences in the proportion of infiltrating lymphocytes, neutrophils, and monocytes.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Machine learning based prediction of recurrence after curative resection for rectal cancer 96%
- Cluster analysis on high dimensional RNA-seq data with applications to cancer research- An evaluation study 95%
- A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with BRAF/MEK-inhibitors evidenced by an algorithm-defined pyrexia score 94%
Similar papers in this journal
Similar papers in this journal
- Use of high-plex data reveals novel insights into the tumour microenvironment of clear cell renal cell carcinoma 96%
- A novel molecular analysis approach in colorectal cancer suggests new treatment opportunities 95%
- COL7A1 expression improves prognosis prediction for patients with clear cell renal cell carcinoma atop of stage 95%
Similar papers in this journal
- Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning 95%
- Dissected subgroups predict the risk of recurrence of stage II colorectal cancer and select rational treatment 94%
- Machine Learning Identifies Complicated Sepsis Trajectory and Subsequent Mortality Based on 20 Genes in Peripheral Blood Immune Cells at 24 Hours post ICU admission 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.